Literature DB >> 4812258

Antitumor action of pyran copolymer and tilorone against Lewis lung carcinoma and B-16 melanoma.

P S Morahan, J A Munson, L G Baird, A M Kaplan, W Regelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4812258

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Monoclonal antibodies to Lewis lung carcinoma.

Authors:  S Ukei; I Saiki; I Azuma
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

2.  Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM).

Authors:  G Sava; T Giraldi; J Tomasić; I Hrsak
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Clinical pharmacology of the biological response modifier maleic anhydride divinyl ether copolymer (MVE-2).

Authors:  M G Rosenblum; A M Rios; E M Hersh
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  The Antiviral Drug Tilorone Is a Potent and Selective Inhibitor of Acetylcholinesterase.

Authors:  Patricia A Vignaux; Eni Minerali; Thomas R Lane; Daniel H Foil; Peter B Madrid; Ana C Puhl; Sean Ekins
Journal:  Chem Res Toxicol       Date:  2021-01-05       Impact factor: 3.739

5.  The Fruit Hull of Gleditsia sinensis Enhances the Anti-Tumor Effect of cis-Diammine Dichloridoplatinum II (Cisplatin).

Authors:  Kyun Ha Kim; Chang-Woo Han; Seong Hoon Yoon; Yun Seong Kim; Jong-In Kim; Myungsoo Joo; Jun-Yong Choi
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-18       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.